Literature DB >> 3699886

Properties of dermonecrotic toxin prepared from sonic extracts Bordetella bronchiseptica.

K Kume, T Nakai, Y Samejima, C Sugimoto.   

Abstract

A toxin with dermonecrotic activity (DNT) was purified from sonic extracts of Bordetella bronchiseptica L3 of pig origin at phase I by chromatographic and electrophoretic methods. The purification procedure was one developed for obtaining the Pasteurella multocida DNT from sonic extracts with some modifications. Dermonecrotizing activity of B. bronchiseptica-purified DNT was increased by 600-fold compared with that of the crude extract, and the average yield was about 3%. The toxin was homogeneous, as determined by Ouchterlony double immunodiffusion, crossed immunoelectrophoresis, and disk isoelectric focusing in polyacrylamide gels. The toxin gave a single band on polyacrylamide disk gel electrophoresis (PAGE) and sodium dodecyl sulfate-SDS PAGE. The molecular weight of the toxin was ca. 190,000 +/- 5,000, as determined by SDS-PAGE. The isoelectric point of the toxin was ca. 6.5 to 6.6. The minimal necrotizing dose of the toxin for guinea pigs was about 2 ng of protein per 0.1 ml, the 50% lethal dose per mouse was about 0.3 micrograms, and the minimal cytotoxic dose for embryonic bovine lung cells was about 2 ng/ml. The toxin was heat labile and sensitive to inactivation by trypsin, Formalin, and glutaraldehyde. The mildly trypsinized B. bronchiseptica DNT preparation dissociated into two polypeptide chains, with molecular weights of ca. 75,000 +/- 4,000 (fragment 1) and ca. 118,000 +/- 5,000 (fragment 2), after treatment with dithiothreitol-SDS or urea. Upon removal of dithiothreitol and urea from the dissociated DNT preparation, the fragments reassociated, and the DNT that was formed was indistinguishable from the native toxin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3699886      PMCID: PMC261008          DOI: 10.1128/iai.52.2.370-377.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Intranasal infection with Bordetella bronchiseptica in gnotobiotic piglets.

Authors:  M Brassinne; A Dewaele; M Gouffaux
Journal:  Res Vet Sci       Date:  1976-03       Impact factor: 2.534

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Lienotoxicity of Bordetella pertussis in mice.

Authors:  T Iida; T Okonogi
Journal:  J Med Microbiol       Date:  1971-02       Impact factor: 2.472

4.  Heat-labile toxin of Bordetella pertussis purified by preparative acrylamide gel electrophoresis.

Authors:  Y Nakase; K Takatsu; M Tateishi; K Sekiya; T Kasuga
Journal:  Jpn J Microbiol       Date:  1969-12

5.  Pathology of experimental atrophic rhinitis in swine infected with Alcaligenes bronchisepticus or Pasteurella multocida.

Authors:  M Nakagawa; T Shimizu; Y Motoi
Journal:  Natl Inst Anim Health Q (Tokyo)       Date:  1974

6.  Measurement of molecular weights by electrophoresis on SDS-acrylamide gel.

Authors:  K Weber; J R Pringle; M Osborn
Journal:  Methods Enzymol       Date:  1972       Impact factor: 1.600

7.  Atrophic rhinitis produced by intranasal inoculation of Bordetella bronchiseptica in hysterectomy produced colostrum-deprived pigs.

Authors:  T Shimizu; M Nakagawa; S Shibata; K Suzuki
Journal:  Cornell Vet       Date:  1971-10

8.  Pathology of experimental Bordetella bronchiseptica infection in swine: atrophic rhinitis.

Authors:  J R Duncan; R F Ross; W P Switzer; F K Ramsey
Journal:  Am J Vet Res       Date:  1966-03       Impact factor: 1.156

9.  Nasal infection of Alcaligenes bronchisepticus (Bordetella bronchiseptica) and lesions in newborn rabbits.

Authors:  M Maeda; T Shimizu
Journal:  Natl Inst Anim Health Q (Tokyo)       Date:  1975

10.  Histamine-sensitizing factor, mouse-protective antigens, and other antigens of some members of the genus Bordetella.

Authors:  R Ross; J Munoz; C Cameron
Journal:  J Bacteriol       Date:  1969-07       Impact factor: 3.490

View more
  17 in total

1.  Purification and characterization of a UDP-glucosyltransferase produced by Legionella pneumophila.

Authors:  Iouri Belyi; Michel R Popoff; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

2.  Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule.

Authors:  I Marsili; M Pizza; F Giovannoni; G Volpini; M Bartalini; R Olivieri; R Rappuoli; L Nencioni
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

3.  Purification and characterization of the heat-labile toxin of Bordetella pertussis.

Authors:  Y L Zhang; R D Sekura
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

4.  Cloning, expression, and molecular characterization of the dermonecrotic toxin gene of Bordetella spp.

Authors:  G D Pullinger; T E Adams; P B Mullan; T I Garrod; A J Lax
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough.

Authors:  L Nencioni; M Pizza; M Bugnoli; T De Magistris; A Di Tommaso; F Giovannoni; R Manetti; I Marsili; G Matteucci; D Nucci
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

6.  Adherence of Pasteurella multocida or Bordetella bronchiseptica to the swine nasal epithelial cell in vitro.

Authors:  T Nakai; K Kume; H Yoshikawa; T Oyamada; T Yoshikawa
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

7.  Isolation and characterization of mutant strains of Bordetella bronchiseptica lacking dermonecrotic toxin-producing ability.

Authors:  H Nagano; T Nakai; Y Horiguchi; K Kume
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

8.  Clonal diversity and host distribution in Bordetella bronchiseptica.

Authors:  J M Musser; D A Bemis; H Ishikawa; R K Selander
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

9.  Virulence factors of Bordetella bronchiseptica associated with the production of infectious atrophic rhinitis and pneumonia in experimentally infected neonatal swine.

Authors:  R M Roop; H P Veit; R J Sinsky; S P Veit; E L Hewlett; E T Kornegay
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

Review 10.  Human infections associated with Bordetella bronchiseptica.

Authors:  B F Woolfrey; J A Moody
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.